Results 21 to 30 of about 175,494 (162)

Sublingual Immunotherapy

open access: yes, 2015
One of the most common reasons people seek primary care and emergency care is to reduce the symptoms of allergies, such as hay fever. To meet this high demand, several recent FDA-approved methods for treating seasonal and perennial allergies have been ...
Ferrell, Melissa Leann
core   +4 more sources

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

open access: yes, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
B Kaambwa   +15 more
core   +1 more source

Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma

open access: yes, 2020
Asthma is a heterogeneous disease that in children is often allergen-driven with a type 2 inflammation. Sublingual immunotherapy represents an important progress in the use of personalized medicine in children with allergic asthma.
Caffarelli, Carlo   +7 more
core   +1 more source

NEW LOOK ON SPECIFIC IMMUNOTHERAPY IN CHILDREN

open access: yesМедицинский совет, 2016
Objective of the Review: introduce modern ideas about the allergen-specific immunotherapy (ASIT) in children.Key Points: The article presents data about frequency of sensibilization and allergic respiratory diseases in children.
T. N. Surovenko, E. F. Glushkova
doaj   +1 more source

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis

open access: yesOpen Medicine, 2021
Few studies investigated the effects of sublingual immunotherapy (SLIT) on the peripheral regulatory T cells (Tregs)/Th17 ratio.
Wang Jiarong   +3 more
doaj   +1 more source

Extracts from The Cochrane Library: Sublingual immunotherapy for allergic rhinitis.

open access: yes, 2011
The "Cochrane Corner" is a quarterly section in the Journal that highlights systematic reviews relevant to otolaryngology-head and neck surgery, with invited commentary to aid clinical decision making. This installment features an updated Cochrane Review
John H. Krouse   +2 more
core   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

open access: yesBMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim   +9 more
wiley   +1 more source

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells

open access: yesFrontiers in Immunology, 2020
Application of allergens onto the sublingual epithelium is used to desensitize allergic individuals, a treatment known as sublingual immunotherapy. However, the response of sublingual epithelial cells to house dust mite allergen and potential tolerance ...
Michael P. Pelst   +8 more
doaj   +1 more source

System‐Local Axes and Metabolic Reprogramming From Health to Response in House Dust Mite‐Specific Subcutaneous Immunotherapy for Allergic Rhinitis

open access: yesiMetaMed, EarlyView.
This study delineated nasal‐plasma metabolic reprogramming in house dust mite‐allergic rhinitis (HDM‐AR) and subcutaneous immunotherapy (SCIT) response, showing compartment‐specific signatures dominated by nasal lipid‐redox and plasma nucleotide‐NAD+ axes and across the HC–HDM‐AR–SCIT response continuum, dual‑compartment metabolites exhibited ...
Bixing Fang   +13 more
wiley   +1 more source

Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment

open access: yesBMC Family Practice, 2008
Background For respiratory allergic disorders in children, sublingual immunotherapy has been developed as an alternative to subcutaneous immunotherapy.
de Jongste Johan C   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy